RBC and plasma physiological metrics in patients with TDT across transfusion
| Variable . | Before . | After . | Week . | P value . | RBC units . | P value . |
|---|---|---|---|---|---|---|
| Hemolysis rate | ||||||
| Cell-free Hb, mg/dL | 13.3 ± 11.4 | 16.4 ±14.5∗ | 11.7 ± 11.7† | .008 | 72.6 ± 65.4∗ | <.001 |
| Osmotic hemolysis, MCF, NaCl% | 0.378 ± 0.048 | 0.385 ± 0.043 | 0.385 ± 0.042 | .077 | 0.458 ± 0.025∗ | <.001 |
| Osmotic hemolysis, 24 hours, MCF, NaCl% | 0.419 ± 0.065 | 0.429 ± 0.057‡ | 0.434 ± 0.056‡ | .061 | 0.493 ± 0.035∗ | <.001 |
| Mechanical hemolysis, MFI, % | 0.732 ± 0.182 | 0.802 ± 0.227∗ | 0.663 ± 0.161∗,† | <.001 | 0.978 ± 0.273∗ | <.001 |
| Oxidative hemolysis, mg/dL | 7.4 ± 7.6 | 6.4 ± 6.0 | 8.4 ± 7.2 | ns | 11.2 ± 9.7∗ | .010 |
| Oxidative stress | ||||||
| ROS, RFU | 652 ± 415 | 524 ± 186 | 686 ± 293† | .023 | 546 ± 233 | ns |
| tBHP-induced ROS, RFU | 3242 ± 1606 | 3085 ± 2339 | 4471 ± 3927 | ns | 2909 ± 2345‡ | .082 |
| PHZ-induced ROS, RFU | 7633 ± 1324 | 8149 ± 1699 | 8215 ± 2621 | ns | 8527 ± 1623∗ | .013 |
| Membrane-bound hemichromes, μΜ | 25.9 ± 6.4 | 26.8 ± 6.7 | 30.2 ± 7.7‡ | .061 | 22.6 ± 5.3‡ | .074 |
| PS+ RBCs, % | 0.86 ± 1.12 | 0.79 ± 1.00 | 0.69 ± 0.93 | ns | 0.23 ± 0.15∗ | <.001 |
| Proteolytic proteasome activity | ||||||
| CH-like, RFU | 29 161 ± 13 451 | 29 690 ± 12915 | 31 618 ± 17 068 | ns | 28 526 ± 13 289 | ns |
| CASP-like, RFU | 19 162 ± 8051 | 18 874 ± 4868 | 19 272 ± 6850 | ns | 19 172 ± 5 936 | ns |
| TR-like, RFU | 48 420 ± 17 168 | 52 596 ± 18410 | 53 394 ± 18 781 | ns | 44 305 ± 12 097 | ns |
| CH-like, m, RFU | 26 209 ± 22 747 | 25 423 ± 15 046 | 36 494 ± 25 101∗,† | .003 | 44 142 ± 30 656∗ | .004 |
| CASP-like, m, RFU | 21 222 ± 19 234 | 22 757 ± 18 233 | 29 478 ± 19 267∗,† | .007 | 35 463 ± 27 523∗ | .011 |
| TR-like, m, RFU | 27 755 ± 28 048 | 26 053 ± 21 901 | 31 217 ± 25 752 | ns | 29 430 ± 20 838 | ns |
| Plasma sEVs | ||||||
| sEV concentration, ×1010/mL | 20.2 ± 8.4 | 20.4 ± 9.5 | 21.2 ± 9.6 | ns | 7.4 ± 3.3∗ | .004 |
| sEV size, nm | 159 ± 24 | 152 ± 25 | 151 ± 28 | .093 | 110 ± 14∗ | <.001 |
| Plasma antioxidant capacity | ||||||
| TAC, μM Fe2+ | 406 ± 91 | 407 ± 87 | 381 ± 86∗,† | .024 | 248 ± 54∗ | <.001 |
| UAiAC, μM Fe2+ | 217 ± 73 | 210 ± 72 | 207 ± 66 | ns | 124 ± 47∗ | <.001 |
| UAdAC, μM Fe2+ | 190 ± 60 | 197 ± 54 | 174 ± 67† | .018 | 124 ± 32∗ | <.001 |
| Variable . | Before . | After . | Week . | P value . | RBC units . | P value . |
|---|---|---|---|---|---|---|
| Hemolysis rate | ||||||
| Cell-free Hb, mg/dL | 13.3 ± 11.4 | 16.4 ±14.5∗ | 11.7 ± 11.7† | .008 | 72.6 ± 65.4∗ | <.001 |
| Osmotic hemolysis, MCF, NaCl% | 0.378 ± 0.048 | 0.385 ± 0.043 | 0.385 ± 0.042 | .077 | 0.458 ± 0.025∗ | <.001 |
| Osmotic hemolysis, 24 hours, MCF, NaCl% | 0.419 ± 0.065 | 0.429 ± 0.057‡ | 0.434 ± 0.056‡ | .061 | 0.493 ± 0.035∗ | <.001 |
| Mechanical hemolysis, MFI, % | 0.732 ± 0.182 | 0.802 ± 0.227∗ | 0.663 ± 0.161∗,† | <.001 | 0.978 ± 0.273∗ | <.001 |
| Oxidative hemolysis, mg/dL | 7.4 ± 7.6 | 6.4 ± 6.0 | 8.4 ± 7.2 | ns | 11.2 ± 9.7∗ | .010 |
| Oxidative stress | ||||||
| ROS, RFU | 652 ± 415 | 524 ± 186 | 686 ± 293† | .023 | 546 ± 233 | ns |
| tBHP-induced ROS, RFU | 3242 ± 1606 | 3085 ± 2339 | 4471 ± 3927 | ns | 2909 ± 2345‡ | .082 |
| PHZ-induced ROS, RFU | 7633 ± 1324 | 8149 ± 1699 | 8215 ± 2621 | ns | 8527 ± 1623∗ | .013 |
| Membrane-bound hemichromes, μΜ | 25.9 ± 6.4 | 26.8 ± 6.7 | 30.2 ± 7.7‡ | .061 | 22.6 ± 5.3‡ | .074 |
| PS+ RBCs, % | 0.86 ± 1.12 | 0.79 ± 1.00 | 0.69 ± 0.93 | ns | 0.23 ± 0.15∗ | <.001 |
| Proteolytic proteasome activity | ||||||
| CH-like, RFU | 29 161 ± 13 451 | 29 690 ± 12915 | 31 618 ± 17 068 | ns | 28 526 ± 13 289 | ns |
| CASP-like, RFU | 19 162 ± 8051 | 18 874 ± 4868 | 19 272 ± 6850 | ns | 19 172 ± 5 936 | ns |
| TR-like, RFU | 48 420 ± 17 168 | 52 596 ± 18410 | 53 394 ± 18 781 | ns | 44 305 ± 12 097 | ns |
| CH-like, m, RFU | 26 209 ± 22 747 | 25 423 ± 15 046 | 36 494 ± 25 101∗,† | .003 | 44 142 ± 30 656∗ | .004 |
| CASP-like, m, RFU | 21 222 ± 19 234 | 22 757 ± 18 233 | 29 478 ± 19 267∗,† | .007 | 35 463 ± 27 523∗ | .011 |
| TR-like, m, RFU | 27 755 ± 28 048 | 26 053 ± 21 901 | 31 217 ± 25 752 | ns | 29 430 ± 20 838 | ns |
| Plasma sEVs | ||||||
| sEV concentration, ×1010/mL | 20.2 ± 8.4 | 20.4 ± 9.5 | 21.2 ± 9.6 | ns | 7.4 ± 3.3∗ | .004 |
| sEV size, nm | 159 ± 24 | 152 ± 25 | 151 ± 28 | .093 | 110 ± 14∗ | <.001 |
| Plasma antioxidant capacity | ||||||
| TAC, μM Fe2+ | 406 ± 91 | 407 ± 87 | 381 ± 86∗,† | .024 | 248 ± 54∗ | <.001 |
| UAiAC, μM Fe2+ | 217 ± 73 | 210 ± 72 | 207 ± 66 | ns | 124 ± 47∗ | <.001 |
| UAdAC, μM Fe2+ | 190 ± 60 | 197 ± 54 | 174 ± 67† | .018 | 124 ± 32∗ | <.001 |
Before, after, week: repeated measures ANOVA or Friedman (Wilcoxon) tests; RBC units vs before: independent t test or Mann-Whitney U (2 samples) test.
CASP, caspase; CH, chymotrypsin; m; membrane; MCF, mean corpuscular fragility index; MFI, mechanical fragility index; ns, not significant; PHZ, phenylhydrazine; RFU, relative fluorescence units; ROS, reactive oxygen species; sEV, small EVs; TAC, total antioxidant capacity; tBHP, tert-butyl hydroperoxide; TR, trypsin; UAiAC, UA-independent antioxidant capacity; UAdAC, UA-dependent antioxidant capacity.
P < .05 vs before.
P < .05 vs after.
.05 < P < .10 (statistical trend).